In addition, cotreatment of SMO inhibitor and MET inhibitor to HCC827-GR xenografted tumors further suppressed tumor volume, since constitutive MET activation was observed in HCC827-GR cells [97]. The gene discussed is SMO; the disease is neoplasm.